Phyllis J Goodman , Catherine M Tangen , John J Crowley , Susan M Carlin , Anne Ryan , Charles A Coltman Jr. , Leslie G Ford , Ian M Thompson
{"title":"实施前列腺癌预防试验(PCPT)","authors":"Phyllis J Goodman , Catherine M Tangen , John J Crowley , Susan M Carlin , Anne Ryan , Charles A Coltman Jr. , Leslie G Ford , Ian M Thompson","doi":"10.1016/j.cct.2003.11.007","DOIUrl":null,"url":null,"abstract":"<div><p>The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.</p></div>","PeriodicalId":72706,"journal":{"name":"Controlled clinical trials","volume":"25 2","pages":"Pages 203-222"},"PeriodicalIF":0.0000,"publicationDate":"2004-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.cct.2003.11.007","citationCount":"30","resultStr":"{\"title\":\"Implementation of the Prostate Cancer Prevention Trial (PCPT)\",\"authors\":\"Phyllis J Goodman , Catherine M Tangen , John J Crowley , Susan M Carlin , Anne Ryan , Charles A Coltman Jr. , Leslie G Ford , Ian M Thompson\",\"doi\":\"10.1016/j.cct.2003.11.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.</p></div>\",\"PeriodicalId\":72706,\"journal\":{\"name\":\"Controlled clinical trials\",\"volume\":\"25 2\",\"pages\":\"Pages 203-222\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.cct.2003.11.007\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Controlled clinical trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0197245604000029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Controlled clinical trials","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0197245604000029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Implementation of the Prostate Cancer Prevention Trial (PCPT)
The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
